| Article ID | Journal | Published Year | Pages | File Type | 
|---|---|---|---|---|
| 11013312 | Progrès en Urologie - FMC | 2018 | 6 Pages | 
Abstract
												Thanks to the current and expected progress of prostatic imaging methods and the development of focal therapy, targeted prostate biopsies are becoming an inavoidable step in the initial management of prostate cancer. The market of fusion devices is growing steadily and allows a selection taking into account precision, cost, modification of the usual protocol and operating time.
											Keywords
												
											Related Topics
												
													Health Sciences
													Medicine and Dentistry
													Urology
												
											Authors
												G. Fiard, R. Mallet, L. Cormier, J.L. Descotes, J. Defontaines, P. Coloby, F. Kleinclauss, E. Lechevallier, J.L. Moreau, A. De la Taille, A. Ruffion, F. Rozet, G. Fournier, Comité de formation continue Comité de formation continue, 
											